Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Palisade Bio (PALI) Non Operating Income (2016 - 2025)

Palisade Bio (PALI) has disclosed Non Operating Income for 16 consecutive years, with $59000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Non Operating Income fell 44.34% to $59000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $239000.0, a 58.22% decrease, with the full-year FY2024 number at $433000.0, down 44.84% from a year prior.
  • Non Operating Income was $59000.0 for Q3 2025 at Palisade Bio, up from $58000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $11.1 million in Q3 2021 to a low of -$2.1 million in Q1 2021.
  • A 5-year average of $919388.9 and a median of $188000.0 in 2023 define the central range for Non Operating Income.
  • Peak YoY movement for Non Operating Income: surged 1110200.0% in 2021, then tumbled 96.16% in 2022.
  • Palisade Bio's Non Operating Income stood at $11.1 million in 2021, then tumbled by 77.05% to $2.5 million in 2022, then crashed by 92.66% to $187000.0 in 2023, then plummeted by 78.07% to $41000.0 in 2024, then soared by 43.9% to $59000.0 in 2025.
  • Per Business Quant, the three most recent readings for PALI's Non Operating Income are $59000.0 (Q3 2025), $58000.0 (Q2 2025), and $81000.0 (Q1 2025).